0202411110603: Difference between revisions

From STARDIT
Jump to navigation Jump to search
No edit summary
No edit summary
Line 30: Line 30:
|con_cop=paid
|con_cop=paid
|con_dates=No
|con_dates=No
}}
|output_parameter={{output parameter
|out_typ=other
|out_out=Application decisions
|out_dates=No
|out_url_oth=http://www.msac.gov.au/internet/msac/publishing.nsf/Content/application-page
|out_imp=Impacts and informs Federal Government decision-making on health technology assessment, by providing advice to Government on whether a new medical service should be publicly funded (and if so, its circumstances) on an assessment of its comparative safety, clinical effectiveness, cost-effectiveness, and total cost, using the best available evidence.
}}
}}
}}
}}

Revision as of 04:11, 12 November 2024

Medical Services Advisory Committee - Expert Standing Committees Description: The Medical Services Advisory Committee (MSAC) has several Expert Standing Committees (ESCs) which provide specialist advice and make recommendations to the MSAC on a range of medical services and technologies. The ESCs are composed of experts in various fields of medicine and health technology assessment.
STARDIT ID: 0202411110603
Dates

State ongoing
Start 1998-01-01
Form updated 2024-11-12

Report authors
Jack Nunn (link)
0000-0003-0316-3254
Aims
provide specialist advice to the MSAC
make recommendations on medical services and technologies
assist in the assessment of the safety, clinical effectiveness, and cost-effectiveness of medical services
Keywords
medical services
health technology
assessment
advice
Category
research

Inputs

organisation

Department of Health (link)



Task: Funding, providing resourcing for organisation and Secretariat support
group of individuals

Expert Standing Committee Members (varies) (link)



Task: Assess items
Compensation: paid

Outputs and impacts

other

Application decisions (link)



Impact: Impacts and informs Federal Government decision-making on health technology assessment, by providing advice to Government on whether a new medical service should be publicly funded (and if so, its circumstances) on an assessment of its comparative safety, clinical effectiveness, cost-effectiveness, and total cost, using the best available evidence.